These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


335 related items for PubMed ID: 12723953

  • 21. Synthesis and antibacterial activity of 1-(2-fluorovinyl)-7-substituted-4-quinolone-3-carboxylic acid derivatives, conformationally restricted analogues of fleroxacin.
    Asahina Y, Iwase K, Iinuma F, Hosaka M, Ishizaki T.
    J Med Chem; 2005 May 05; 48(9):3194-202. PubMed ID: 15857125
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Synthesis and structure-activity relationship of 7-(substituted)-aminomethyl-4-quinolone-3-carboxylic acid derivatives.
    Zhang Z, Yu A, Zhou W.
    Bioorg Med Chem; 2007 Dec 01; 15(23):7274-80. PubMed ID: 17826097
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Synthesis and antibacterial activity of dl-7-(4,4-dimethyl-3-aminomethylpyrrolidinyl) -quinolones].
    Wang YC, Wang XY, Liu JY, Guo HY.
    Yao Xue Xue Bao; 2006 Jan 01; 41(1):58-64. PubMed ID: 16683529
    [Abstract] [Full Text] [Related]

  • 26. Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones.
    Cecchetti V, Fravolini A, Lorenzini MC, Tabarrini O, Terni P, Xin T.
    J Med Chem; 1996 Jan 19; 39(2):436-45. PubMed ID: 8558512
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and antibacterial activity of the 4-quinolone-3-carboxylic acid derivatives having a trifluoromethyl group as a novel N-1 substituent.
    Asahina Y, Araya I, Iwase K, Iinuma F, Hosaka M, Ishizaki T.
    J Med Chem; 2005 May 05; 48(9):3443-6. PubMed ID: 15857152
    [Abstract] [Full Text] [Related]

  • 28. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives.
    Zhang YB, Feng LS, You XF, Guo Q, Guo HY, Liu ML.
    Arch Pharm (Weinheim); 2010 Mar 05; 343(3):143-51. PubMed ID: 20186866
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin-3-yl)}-phenyl] -ethyl]-piperazin-1-yl}-fluoroquinolones].
    Yu HJ, Zhou WC.
    Yao Xue Xue Bao; 2006 Oct 05; 41(10):990-9. PubMed ID: 17184119
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: novel C7 moieties of fluoroquinolones as antibacterial agents.
    Huang X, Zhang A, Chen D, Jia Z, Li X.
    Bioorg Med Chem Lett; 2010 May 01; 20(9):2859-63. PubMed ID: 20347299
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The synthesis and biological evaluation of a novel series of C7 non-basic substituted fluoroquinolones as antibacterial agents.
    Huang X, Chen D, Wu N, Zhang A, Jia Z, Li X.
    Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4130-3. PubMed ID: 19539467
    [Abstract] [Full Text] [Related]

  • 37. Structure-activity relationships in quinolone antibacterials: design, synthesis and biological activities of novel isothiazoloquinolones.
    Chu DT, Fernandes PB, Claiborne AK, Shen L, Pernet AG.
    Drugs Exp Clin Res; 1988 Aug 01; 14(6):379-83. PubMed ID: 2850902
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and antibacterial evaluation of isoxazolinyl oxazolidinones: Search for potent antibacterial.
    Varshney V, Mishra NN, Shukla PK, Sahu DP.
    Bioorg Med Chem Lett; 2009 Jul 01; 19(13):3573-6. PubMed ID: 19447611
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Synthesis and antibacterial activity of a novel series of DNA gyrase inhibitors: 5-[(E)-2-arylvinyl]pyrazoles.
    Tanitame A, Oyamada Y, Ofuji K, Terauchi H, Kawasaki M, Wachi M, Yamagishi J.
    Bioorg Med Chem Lett; 2005 Oct 01; 15(19):4299-303. PubMed ID: 16087337
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.